The North America cancer vaccines market is expected to maintain a significant position in the global landscape through 2031, supported by the rising incidence of cancer, substantial healthcare expenditure, advanced research infrastructure, and increasing investments in innovative cancer immunotherapies. The region comprises the US, Canada, and Mexico and held a significant share of the global...